Navigation Links
AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team

TUSTIN, Calif., Nov. 6 /PRNewswire-FirstCall/ -- ( AMDL, Inc. (Amex: ADL), today announced the promotion of its CFO, Mr. Akio Ariura, to Chief Operating Officer (COO) and CFO. The Company is also expanding its management team with the addition of Mr. Christopher Gee as Director of International Marketing and Sales and Mr. Raymond Gatchalian as Director of Compliance and Information Technology.

As COO and CFO, Mr. Ariura will lead the day-to-day operations of AMDL, including direct responsibility for AMDL's legal, financial, and business affairs; employee development and recruiting; and high-priority companywide initiatives, including the implementation of its Kingdee ERP accounting system within the US and China; joint venture and partnership implementations; and the development of brand and product commercialization strategies across all business divisions.

"I am extremely pleased with the Board's decision to promote Akio to Chief Operating Officer of AMDL," said Mr. Douglas MacLellan, CEO and Chairman, AMDL. "He has been instrumental in the Company's success to date, and broadening his role is a next step as we continue to grow and expand our business. With the support of his leadership and business expertise, AMDL is on-target to meet its gross revenue targets of $30 million to $38 million this year. I'm genuinely excited to have Akio in this newly created senior executive position as we focus on building AMDL as a world-class and market-leading, diversified pharmaceutical company."

Mr. Ariura joined AMDL in 2006 as the Chief Financial Officer. He holds more than 20 years of experience in senior finance and business operations positions with various public and private companies. Mr. Ariura is a certified public accountant and recognized as a Small-Cap SOX compliance expert.

"I'm pleased to transition to this role during such a defining time in AMDL's history. With nearly 500% annual growth over the past three years we've managed to thrive and evolve, despite market uncertainty and recent economic instability," commented Mr. Ariura. "In fact, what I am most proud of is how we've continued to expand our sales and distribution throughout China, with top-line sales that far exceed goals set during our 2007 planning cycle."

AMDL is also expanding its senior management team with the appointment of Mr. Christopher Gee as Director of International Marketing and Sales and Mr. Raymond Gatchalian as Director of Compliance and Information Technology.

Mr. MacLellan continued, "This latest round of executive appointments further complements the top-notch team we have assembled. They are highly qualified, dedicated professionals with the depth of experience and professional tenure to help take AMDL to the next level. I'm pleased to welcome Chris and Ray aboard."

Mr. Gee is a former Apple Inc. executive and tech/biotech industry veteran with extensive IT, business operations, and international sales and marketing management experience. Since 2004 he has held executive positions and worked on projects in the USA, PRC China, Hong Kong, and Taiwan including IT management, product development, marketing, sales and distribution. His oversight spanned US and Asian business operations. His background includes three years as a senior analyst at New York University, Stern School of Business. Mr. Gee has also been a principal in various start-up companies. While at Apple Inc., Mr. Gee successfully managed business development and enterprise computing projects. Mr. Gee holds a Masters degree from Kings College, University of London and a Bachelors degree from New York University.

Mr. Gatchalian has an extensive background in IT audit and compliance. He has worked for both large and small companies including Pacificare Health Systems, Corinthian Colleges and Fremont Investment and Loan and as a consultant with Deloitte & Touche, Jefferson Wells, Countrywide Financial and Diagnostics Products International, with the primary responsibility of planning, conducting and managing system audits and providing consulting services to various IT organizations. Mr. Gatchalian received his B.S. in Computer Information Systems from the DeVry Institute of Technology.

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs approximately 320 people in the U.S. and China. The Company has an additional 4 pharmaceutical and diagnostic products under review by various regulatory authorities.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward- looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL, Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties related to the Company's access to additional capital, competition and dependence on key management.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations

(M) (206) 310-5323

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
2. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
3. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
4. AMDL, Inc. Closes Private Placement of Convertible Notes
5. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
6. AMDL, Inc. Announces Strategic Realignment
7. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
8. AMDL, Inc.s President & CEO Mr. Gary Dreher Retires
9. AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
10. Enzyme promotes fat formation
11. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
Post Your Comments:
(Date:10/8/2015)... IRVINE, Calif. , Oct. 8, 2015 ... announced its expansion into the North American market with ... Asia and Europe ... a pioneer of Target Enrichment methodology and sample preparation ... or NGS, facilitates both hereditary and somatic genetic testing ...
(Date:10/8/2015)... 2015  The ALS Association, in partnership with Prize4Life, ... to revolutionize communication technology solutions for people living with ... ALS (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease ... the spinal cord. Eventually, people with ALS lose the ... leads to total paralysis and death within two to ...
(Date:10/8/2015)... ... October 08, 2015 , ... ProMIS Neurosciences, Inc. (TSX: ... develop and commercialize intellectual property rights belonging to The University of British Columbia ... affords exclusive worldwide rights to intellectual property based on use of the ProMIS™ ...
(Date:10/7/2015)... ... October 07, 2015 , ... The Riordan-McKenna Institute ( ... educational seminar on the latest advances in adult stem cell therapy for orthopedic ... pm at the Hilton Dallas/Southlake Town Square in Southlake, Texas. , RMI offers ...
Breaking Biology Technology:
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), ... ) focused on bringing the life saving ... said today that Matthew Schissler, founder and CEO, in ... Company is very close to becoming cash flow positive.The ...
... CRY ), a biomaterials, medical device and tissue processing company, ... results will be released on Thursday, February 19, 2009. ... at 10:00 a.m. Eastern Time, February 19, 2009, to discuss ... by Steven G. Anderson, president and CEO of CryoLife, Inc.To ...
... INCHEON, South Korea, Feb. 5 The Centers for ... Korean,biopharmaceutical company, have signed a Letter of Intent to ... protect people exposed to,the rabies virus. , ... rabies is a two-step procedure.,First, rabies immune globulin (RIG) ...
Cached Biology Technology:
(Date:9/30/2015)... , Sept. 30, 2015  The global glucose monitoring device ... 2015. So says a new report on the industry from ... segment dominate the market, followed by continuous glucose monitoring and ... on the market for these products in its latest report, ... , ...
(Date:9/29/2015)... 2015  iDAvatars is excited to be named one of ... market. The official announcement was recently made at an invite-only ... San Francisco , where iDAvatars presented a ... Watson. "It is both an honor and a ... bring to market the cognitive power of IBM Watson in ...
(Date:9/28/2015)... 2015  The monitoring of vital signs, such ... is an essential component of patient assessment. Changes ... in a patient,s condition. However, in general care ... taken during routine observation rounds only once every ... between these observation rounds, the warning signs can ...
Breaking Biology News(10 mins):
... it can damage blood vessels and increase the risk of ... he can thin the human blood by subjecting it to ... physics at Temple University, has pioneered the use of electric ... engines and pipelines. Now, he is using the same magnetic ...
... coastal areas in Africa can rarely utilise their entire fishing ... near the coast. Research carried out by economist Kofi Vondolia ... of fish stocks is significant to fish management. ... allows foreign fishing fleets to utilise the zones further out ...
... the Virginia Institute of Marine Science (VIMS) shows that jellyfish ... altering marine food webs by shunting food energy from fish ... frequency of jellyfish blooms in coastal and estuarine waters around ... impact on marine food webs is likely to increase into ...
Cached Biology News:
... preparation of the catalytic subunit of bovine ... isolated from the yeast Pichia pastoris to ... It recognizes the sequence Asp-Asp-Asp-Asp-Lys and cleaves ... The enzyme can be used to cleave ...
... bioassays for interferons are cytopathic effect inhibition assays, ... Sample types include; tissue culture supernatents; serum from ... assays, one unit is defined as the quantity ... cytopathic effect of viral infection by 50%. ...
Biology Products: